Converge Bio Uses AI To Enhance Cancer Therapy With Single Prompt
Israeli startup Converge Bio enhanced cancer drug cetuximab using AI, generating 100,000 antibody candidates and identifying a stronger option.
Israeli startup Converge Bio enhanced cancer drug cetuximab using AI, generating 100,000 antibody candidates and identifying a stronger option.